ArticleHeart and vessels2026
Autonomic modulation in functional tricuspid regurgitation: effects of transcatheter valve repair.
Article in Heart and vessels, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Response to the letter to the editor: sympathetic overactivation in patients undergoing transcatheter tricuspid valve repair.Heart and vessels · 2026Article
- Reconsidering the association between transcatheter tricuspid valve repair and sympathetic activity.Heart and vessels · 2026Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To assess the impact of functional tricuspid regurgitation (FTR) and transcatheter tricuspid valve repair (TTVR) on sympathetic nerve activity (SNA). Increased SNA is associated with adverse outcomes and reduced survival in patients with valvular heart disease and chronic heart failure (CHF). However, the effect of interventional treatment of FTR on SNA remains unclear. Twenty-eight patients with symptomatic FTR ≥ grade III underwent TTVR (either edge-to-edge repair or direct annuloplasty). Muscle sympathetic nerve activity (MSNA) was assessed via microneurography. While all patients completed the 12-month follow-up, repeated MSNA assessment was feasible in 10. In patients with symptomatic severe FTR, baseline MSNA was markedly elevated (incidence: 192.8 bursts/100 beats; frequency: 167.8 bursts/min). At 12-month follow-up, tricuspid regurgitation severity was significantly reduced (median grade 3 [IQR 3-4] vs. 2 [IQR 1-2]; p < 0.01), accompanied by improved functional status (NYHA class 3 [IQR 3-4] vs. 2 [IQR 1-3], p < 0.01; 53% ≤ NYHA II). NT-proBNP showed a non-significant decline (p = 0.09), while LV function, MR severity, and renal function remained unchanged. MSNA incidence decreased to 72.6 bursts/100 beats (p = 0.01), and frequency to 93.4 bursts/min (p = 0.001). Patients with FTR exhibit markedly increased SNA. TTVR was associated with a significant reduction in MSNA, suggesting a neurophysiological mechanism contributing to clinical improvement beyond hemodynamic relief.
Indexed as
Identifiers
42319432What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.